These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 31251139)
1. Self-Assembled Hyaluronic Acid Nanoparticles for pH-Sensitive Release of Doxorubicin: Synthesis and Hu R; Zheng H; Cao J; Davoudi Z; Wang Q J Biomed Nanotechnol; 2017 Dec; 13(9):1058-1068. PubMed ID: 31251139 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and Hu R; Zheng H; Cao J; Davoudi Z; Wang Q J Biomed Nanotechnol; 2017 Dec; 13(9):1097-1105. PubMed ID: 31251142 [TBL] [Abstract][Full Text] [Related]
3. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy. Lu B; Xiao F; Wang Z; Wang B; Pan Z; Zhao W; Zhu Z; Zhang J ACS Biomater Sci Eng; 2020 Jul; 6(7):4106-4115. PubMed ID: 33463311 [TBL] [Abstract][Full Text] [Related]
4. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy. Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743 [TBL] [Abstract][Full Text] [Related]
5. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers. Huang X; Liao W; Xie Z; Chen D; Zhang CY Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091 [TBL] [Abstract][Full Text] [Related]
6. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells. Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666 [TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin. Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869 [TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA. Wang T; Yu X; Han L; Liu T; Liu Y; Zhang N Int J Nanomedicine; 2017; 12():4773-4788. PubMed ID: 28740384 [TBL] [Abstract][Full Text] [Related]
9. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy. Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronan Based Tumor-Targeting and pH-Responsive Shell Cross-Linkable Nanoparticles for the Controlled Release of Doxorubicin. Liao J; Zheng H; Hu R; Cao J; Wei X; Li D; Zheng H; Yin Y J Biomed Nanotechnol; 2018 Mar; 14(3):496-509. PubMed ID: 29663922 [TBL] [Abstract][Full Text] [Related]
11. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid. Wang X; Gu X; Wang H; Yang J; Mao S Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965 [TBL] [Abstract][Full Text] [Related]
12. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery. Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700 [TBL] [Abstract][Full Text] [Related]
13. Facile preparation of pH-sensitive micelles self-assembled from amphiphilic chondroitin sulfate-histamine conjugate for triggered intracellular drug release. Yu C; Gao C; Lü S; Chen C; Yang J; Di X; Liu M Colloids Surf B Biointerfaces; 2014 Mar; 115():331-9. PubMed ID: 24398081 [TBL] [Abstract][Full Text] [Related]
14. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy. Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180 [TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester. Jäger E; Jäger A; Chytil P; Etrych T; Ríhová B; Giacomelli FC; Stěpánek P; Ulbrich K J Control Release; 2013 Jan; 165(2):153-61. PubMed ID: 23178950 [TBL] [Abstract][Full Text] [Related]
16. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy. Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789 [TBL] [Abstract][Full Text] [Related]
17. pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery. Qiu L; Zhu M; Gong K; Peng H; Ge L; Zhao L; Chen J Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():912-922. PubMed ID: 28576067 [TBL] [Abstract][Full Text] [Related]
18. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
19. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation. Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356 [TBL] [Abstract][Full Text] [Related]
20. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin. Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]